Fasenra Pediatric Japan Post-Marketing Study(PMS)
Recruiting
- Conditions
- Bronchial Asthma
- Registration Number
- NCT06427876
- Lead Sponsor
- AstraZeneca
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Inclusion Criteria:<br><br>The evaluable patients in children aged =6 years to <15 years are those treated with<br>Fasenra for the first time due to Bronchial asthma (only the patients with intractable<br>bronchial asthma which could not be controlled with the existing therapy)<br><br>Exclusion Criteria:<br><br>none
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of ADRs
- Secondary Outcome Measures
Name Time Method